Abstract
Exfoliative glaucoma (XFG) is the most common type of secondary open-angle glaucoma.1 Its worldwide prevalence makes it critical for ophthalmologists to be familiar with the full clinical spectrum of the disease.1–3 Exfoliation syndrome (XFS) and XFG were initially described in 1917 by the Finnish ophthalmologist John Lindberg. In 1924, it was determined that XFG develops from XFS. Both conditions currently affect 60-70 million people worldwide. Of these, 15-17 million people have increased intraocular pressure (IOP) and 5-6 million are estimated to suffer from XFG.3 Both XFS and XFG are characterized by the systemic synthesis and accumulation of an abnormal fibrillar material, called exfoliation material. Originally it was believed that the sole source of this abnormal material is the lens. The terms exfoliation material, XFS, XFG, and capsular glaucoma were introduced based on this early theory. True exfoliation of the lens capsule is a different and an exceedingly rare entity, which occurs as a consequence of thermal damage of the lens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265–315.
Ringvold A. Epidemiology of the pseudoexfoliation syndrome. A review. Acta Ophthalmol Scand. 1999;77:371–375.
Ritch R, Schlotzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res. 2003;22:253–275.
Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317:1397–1400.
Fingert JH, Alward WA, Kwon YH, Wang K, Streb LM. LOXL1 mutations are associated with exfoliation syndrome in patients from the Midwestern United States. Am J Ophthalmol. 2007;144:974–975.
Pasutto F, Krumbiegel M, Marin CY, et al. Associations of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1459–1463.
Ozaki M, Lee KYC, Vithana FN, et al. Association of LOXL1 gene polymorphism with pseudoexfoliation in the Japanese. Invest Ophthalmol Vis Sci. 2008;49:3976–3980.
Hayashi H, Gotoh N, Ueda Y, Nakanishi H, Yoshimura N. Lysyl oxidase-like 1 polymorphism and exfoliation syndrome in the Japanese population. Am J Ophthalmol. 2008;145:582–585.
Schlötzer-Schrehardt U, Naumann GOH. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. Invest Ophthalmol Vis Sci. 1995;36:1750–1764.
Naumann GOH, Shclötzer-Schrehardt U, Kühle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Ophthalmology. 1998;105:951–968.
Koliakos GG, Konstas AGP, Schrehardt-Schloetzer U, Bufidis T, Georgiadis N, Ringvold A. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol. 2002;134:879–883.
Visontai ZS, Horváth T, Kollai M, Holló G. Decreased cardiovagal regulation in exfoliation syndrome. J Glaucoma. 2008;17:133–138.
Visontai Z, Merisch B, Kollai M, Holló G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol. 2006;90:563–567.
Mitchell P, Wang JJ, Smith W. Association of pseudoexfolation syndrome with increased vascular risk. Am J Ophthalmol. 1997;124: 85–687.
Tarkkanen A, Kivelä T. Cumulative incidence of converting from clinically unilateral to bilateral exfoliation syndrome. J Glaucoma. 2004;13:181–184.
Puska P. Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma. A prospective 10-year follow-up study. J Glaucoma. 2002;11:517–524.
Konstas AGP, Matziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;28:111–117.
Konstas AGP, Holló G, Astakhov YS, et al. Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain, Russia and Hungary. Eur J Ophthalmol. 2006;16:60–66.
Thygesen J. Ocular clinical findings in exfoliation syndrome. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2008:105–112.
Teus MA, de Benito-Llopis L. Update on cataract surgery in exfoliation syndrome. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2007:127–132.
Vesti E, Kivel AT. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19:268–345.
Konstas AGP, Tsironi S, Kozobolis VP. Medical therapy of exfoliative glaucoma. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2008:137–144.
Konstas AGP, Holló G, Akopov EL, et al. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol. 2004;122:29–33.
Konstas AGP, Tsironi S, Ritch R. Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma. Compr Ophthalmol Update. 2006;7:131–141.
Takki KK, Klemetti A, Valle O. The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland. Graefes Arch Clin Exp Ophthalmol. 1982;218:83–87.
Blika S, Saunte E. Timolol maleate in the treatment of glaucoma simplex and glaucoma capsulare. A three-year follow up study. Acta Ophthalmol (Copenh). 1982;60:967–976.
Konstas AG, Matziris DA, Gate EA, Stewart WC. Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;115:975–979.
Heijl A, Strahlman E, Sverrisson T, et al. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension. Ophthalmology. 1997;104:137–142.
Konstas AGP, Maltezos A, Bufidis T, Hudgins AG, Stewart WC. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Eye. 2000;14:73–77.
Parmaksiz S, Yuksel N, Karabas VL, Ozkan B, Demirci G, Caglar Y. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma. Eur J Ophthalmol. 2006;16:73–80.
Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Eye. 2003;17:41–46.
Konstas AG, Mylopoulos N, Karabatsas CH, et al. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye. 2004;18:893–899.
Konstas AGP, Kozobolis VP, Katsimpris IE, et al. Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients. Ophthalmology. 2007;114:653–657.
Konstas AGP, Holló G, Irkec M, et al. Diurnal IOP control with bimatoprost vs latanoprost in exfoliative glaucoma: a crossover observer-masked 3-center study. Br J Ophthalmol. 2007;91:757–760.
Stewart WC, Konstas AGP, Nelson LA, Kruft B. Meta-analysis of 24-hour intraocular pressure studies evaluating efficacy of glaucoma medicines. Ophthalmology. 2008;115:1117–1122.
Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N. Comparison of additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized open-label, multicenter study in Greece. J Glaucoma. 2001;10:316–324.
Odberg T. Laser therapy of exfoliative glaucoma. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2008:149–153.
Odberg T, Sandvik L. The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand. 1999;77:176–181.
Threlkeld A, Hertzmark E, Sturm RT, et al. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma. 1996;5:311–316.
Higginbotham EJ, Richardson TM. Response of exfoliation glaucoma to laser trabeculoplasty. Br J Ophthalmol. 1986;70:837–839.
Psilas P, Prevezas D, Petroutsos G, et al. Comparative study of argon laser trabeculoplasty in primary open-angle and pseudoexfoliation glaucoma. Ophthalmologica. 1989;198:57–63.
Tuulonen A, Niva A-K, Alanko HI. A controlled five-year follow-up study of laser trabeculoplasty as primary therapy for open-angle glaucoma. Am J Ophthalmol. 1987;104:334–338.
Hodge WG, Damji KF, Rock W, Buhrmann R, Bowel AM, Pan Y. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol. 2005;89:1157–1160.
Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma. Arch Ophthalmol. 2003;121:957–960.
Kozobolis VP, Konstas AGP. Filtering surgery in exfoliative glaucoma. In: Holló G, Konstas AGP, eds. Exfoliation Syndrome and Exfoliative Glaucoma. Savona, Italy: Dogma S.r.l; 2008:157–161.
Tφrnqvist G, Drolsum L. Trabeculectomies. A long-term study. Acta Ophthalmol (Copenh). 1991;69:450–454.
Popovic V, Sjostrand J. Course of exfoliation and simplex glaucoma after primary trabeculectomy. Br J Ophthalmol. 1999;83: 305–310.
Konstas AGP, Jay JL, Marshall GE, Lee WR. Prevalence, diagnostic features and the response to trabeculectomy in exfoliation glaucoma. Ophthalmology. 1993;100:619–627.
Drolsum L. Deep sclerectomy in patients with capsular glaucoma. Acta Ophthalmol Scand. 2003;81:567–572.
Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma. 2002;11:287–293.
Shaarawy T, Nguyen C, Schnyder C, Mermoud A. Five year results of viscocanalostomy. Br J Ophthalmol. 2003;87:441–445.
Wishart PK, Wishart MS, Porooshani H. Viscocanalostomy and deep sclerectomy for the surgical treatment of glaucoma: a longterm follow-up. Acta Ophthalmol Scand. 2003;81:343–348.
Jacobi PC, Dietlein TS, Krieglstein GK. Comparative study of trabecular aspiration vs trabeculectomy in glaucoma triple procedure to treat pseudoexfoliation glaucoma. Arch Ophthalmol. 1999;117: 1311–1318.
Ritch R, Konstas AGP, Schlötzer-Schrehardt U: Exfoliation syndrome and exfoliative glaucoma. In Glaucoma: Medical diagnosis and therapy, Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG, eds, Saunders 2009;1:339–348.
Acknowledgments
Supported in part by a Pythagoras grant (Dr. Konstas); a Hungarian National Health Grant (ETT 001/2009), (Dr. Holló); and a Horizon Award, Allergan, Inc., and Edith C. Blum Foundation, New York, NY (Dr. Ritch).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Konstas, A.G.P., Holló, G., Ritch, R. (2010). Exfoliation Syndrome and Glaucoma. In: Schacknow, P., Samples, J. (eds) The Glaucoma Book. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76700-0_39
Download citation
DOI: https://doi.org/10.1007/978-0-387-76700-0_39
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-76699-7
Online ISBN: 978-0-387-76700-0
eBook Packages: MedicineMedicine (R0)